Upregulation of EGFR pathway signaling is a common event in several kinds of chronic diseases, especially in cancers such as non-small-cell lung cancer (NSCLC), metastatic colorectal cancer, and glioblastoma (36). This evidence concerns the gene EGFR and glioblastoma.